Scopus Eşleşmesi Bulundu
2
Atıf
57
Cilt
3655-3665
Sayfa
Özet
Purpose: This study aimed to evaluate the diagnostic and therapeutic approaches to premature ejaculation (PE), focusing on variations in clinical practices and guideline adherence. Methods: A structured survey was anonymously distributed via Google Forms to 900 clinicians between April 30 and June 10, 2024, of whom 378 completed the questionnaire, yielding a response rate of 42%. Participants included urologists, andrologists, psychiatrists, and sexual psychotherapists. The questionnaire covered diagnostic criteria, laboratory investigations, treatment preferences, management strategies for comorbid conditions, along with attitudes toward behavioral and invasive interventions. Statistical analyses included descriptive statistics, chi-square, and Fisher’s exact tests. Results: The study revealed marked variability in the diagnosis and treatment of PE. While the ISSM definition was the most commonly used guideline (40.5%), psychiatrists predominantly relied on DSM-5-TR criteria (88.2%). Laboratory testing, including testosterone and thyroid function evaluations, was employed by 54.2% of participants. Dapoxetine was the most preferred first-line therapy (31.2%), followed by behavioral therapies (20.6%) and local anesthetics (19.6%). For patients unresponsive to initial therapies, couple-based sexual psychotherapy (18.6%) and use of long-acting daily SSRIs (14.8%) were the most preferred second-line treatments. Combination therapies were widely adopted (89.1%), though their components varied significantly. Surgical and invasive treatments, such as hyaluronic acid injections, were rarely utilized (18.3%), with most physicians reserving them for refractory cases. Pelvic floor relaxation exercises were recommended by 72% of participants, while 87.5% endorsed behavioral therapies for PE. Conclusion: This study revealed substantial variability in PE management, its multifaceted etiology and guideline limitations. The findings underscore the need for standardized, evidence-based protocols to enhance clinical outcomes and optimize patient satisfaction.
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 2.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2025 yılı verileri
International Urology and Nephrology
Q2
SJR Quartile
0,635
SJR Skoru
73
H-Index
Kategoriler: Nephrology (Q2) · Urology (Q2)
Alanlar: Medicine
Ülke: Netherlands
· Springer Science and Business Media B.V.
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
Bu makale için anahtar kelime bilgisi bulunmuyor.
Makale Bilgileri
Dergi
International Urology and Nephrology
ISSN
1573-2584
Yıl
2025
/ 11. ay
Cilt / Sayı
57
/ 11
Sayfalar
3655 – 3665
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q3
Teşvik Puanı
0,38
· YÖKSİS Akademik Teşvik
Yayın Dili
İngilizce
Kapsam
Uluslararası
Toplam Yazar
11 kişi
Erişim Türü
Elektronik
Alan
Sağlık Bilimleri Temel Alanı
Üroloji
YÖKSİS Yazar Kaydı
Yazar Adı
ÇEKER GÖKHAN,ÇİNAR ÖNDER,TURUNÇ TAHSİN,KIZILKAN YALÇIN,ANIL HAKAN,AKGÜN UĞUR,CENGİZ ÇAVUŞOĞLU EMİNE,DOĞAN ÇAĞRI,BAL HARUN,GÜL ÜMİT,GÜL MURAT
YÖKSİS ID
8911641